...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis.
【24h】

Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis.

机译:免疫缺陷小鼠受体中人冠状动脉移植物的同种免疫介导的血管重塑独立于先前的动脉粥样硬化。

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular remodeling rather than intimal thickening is the most important determinant of luminal loss in cardiac graft arteriosclerosis. The impact of donor-transmitted atherosclerotic lesions on alloimmune-mediated arterial injury in an experimental setting is not known. We investigated this issue in a chimeric model of human coronary artery grafts to immunodeficient mouse recipients reconstituted with allogeneic human peripheral blood mononuclear cells. Rejecting grafts demonstrated robust intimal expansion, outward vascular remodeling, and variable lumen loss. There was no significant relationship between preexistent atherosclerosis, gender, and age of the artery donors vs. the degree of alloimmune-induced changes in vessel morphology. Our experimental findings, in a system without the potentially confounding variable of immunosuppressive drugs, are in agreement with the majority of clinical studies that alloimmune-mediated intimal injury and vascular remodeling is independent of preexisting coronaryatherosclerosis. Our results support the concept of extending the criteria for organ donors to include modest coronary atherosclerosis.
机译:血管重塑而非内膜增厚是心脏移植物动脉硬化中管腔丢失的最重要决定因素。在实验环境中,供体传播的动脉粥样硬化病变对同种免疫介导的动脉损伤的影响尚不清楚。我们在人类冠状动脉移植物的嵌合模型中研究了这个问题,该模型是用异基因人类外周血单核细胞重建的免疫缺陷小鼠受体。排斥移植物表现出强劲的内膜扩张,向外的血管重塑和可变的管腔丢失。既往动脉粥样硬化,性别和动脉供体年龄与同种免疫诱导的血管形态变化程度之间无显着相关性。我们的实验发现在一个没有免疫抑制药物潜在混杂变量的系统中,与大多数临床研究一致,即同种免疫介导的内膜损伤和血管重塑独立于先前存在的冠状动脉粥样硬化。我们的结果支持将器官供体标准扩展到包括中度冠状动脉粥样硬化的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号